ENG
Parenteral Nutrition Market: Global Research Analysis and Forecast (2024-2030) by Nutrition Type, Consumer Type, End-Use, and Region
Parenteral Nutrition Market size was valued at US$ 7.18 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 6.0% through 2024 to 2030, reaching nearly US$ 10.80 Bn
Format : PDF | Report ID : SMR_350
Parenteral Nutrition Market Overview:
Parenteral nutrition delivers sugar, carbohydrates, proteins, fats, electrolytes, and trace elements to the body. Having a high level of energy, hydration, and strength requires these nutrients. It is called parenteral nutrition, sometimes called total parenteral nutrition (intravenously) when a particular form of food is injected into a vein. The treatment is used to treat or prevent malnutrition.
To get more Insights: Request Free Sample Report
Though market forecasting through 2027 is based on real output, demand and supply of 2020, 2020 numbers are also estimated on real numbers published by key players as well all-important players across the world. Market forecasting till 2027 is done based on past data from 2016 to 2019 with the impact of global lock down on the parenteral nutrition market in 2020 and 2021.
COVID-19 Influences on the Parenteral Nutrition Market:
The rising demand for PN (Parenteral Nutrition) to administer intravenous electrolytes, carbohydrates, amino acids, and essential minerals to meet patients' nutritional requirements, as well as the rising incidence of hospital-acquired malnutrition, are the main factors driving parenteral nutrition market. During the pandemic, there was a huge rise of target users. The need for PN has been spurred by an influx of regulatory-approved PN systems, as well as increased R&D initiatives to improve medicine administration.
In the face of the COVID-19 pandemic, the market's major firms are concentrating on improving strategic priorities. Following the pandemic, the market is expected to grow due to increased usage of PN among intensive care patients and surgical wards to lower ventilation duration and death rates. The R&D efforts linked with PN, including as clinical trials, have shown an increase during the pandemic and are expected to continue, providing positive growth potential for the parenteral nutrition market during the forecast period.
Parenteral Nutrition Market Dynamics:
Parenteral nutrition (PN) is the intravenous injection of essential nutrients. Protein, fat, carbohydrate, electrolytes, minerals, vitamins, and essential trace elements are among these nutrients. One of the key factors driving market growth is the growing elderly population, which necessitates the administration of critical nutrients to keep patients hydrated, energetic, and strong.
The rising prevalence of chronic diseases such as malignancies causes low energy levels and a loss of appetite, which is expected to increase demand for parenteral nutrition, driving the parenteral nutrition market forward. The rising incidence of preterm births, as well as the scarcity of vital nutrients in premature infants and newborns, are expected to accelerate the adoption of intravenous nutrition delivery, particularly in Asia Pacific and Africa's developing and poor countries. Growing government and non-government activities to raise awareness of diet, such as the National Association of Nutrition Professionals, the American Association, the American Society for Parenteral and Enteral Nutrition, and others, are expected to boost parenteral nutrition market growth during the forecast period.
Appropriate and timely parenteral feeding can help patients recover faster and avoid problems. Patients with diseases or conditions that impede food intake, digestion, or nutrient absorption, such as short bowel syndrome, gastrointestinal fistulas, intestinal obstruction, critically ill patients, and severe acute pancreatitis, are the most common recipients. Besides, because of the convenience of usage, patients can now get parenteral nutrition at home. Approximately 25,000 patients received parenteral feeding at home, according to estimates. These are the factors that are expected to have a substantial impact on parenteral nutrition market growth.
Lack of understanding and potential side effects of parenteral nutrition, such as changes in heart rate, seizures, rapid weight gain or loss, weariness, fever or chills, increased urination, and memory loss, are the factors that are expected to hamper the global parenteral nutrition market's growth during the forecast period.
Parenteral Nutrition Market Segment Analysis:
Based on the Nutrition Type, the market is segmented into Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals. Single Dose Amino Acid Solution segment is expected to hold the largest market shares of xx% by 2030. This is due to the people's increased awareness of health and fitness, as well as the high prevalence of chronic diseases around the world. Effective monitoring and assessment are one of the most critical parts of PN service. Routine monitoring should include vital signs, blood glucose, fluid balance, and blood and urine biochemistry. Parenteral nutrition issues can be avoided by following proper care standards during the administration process. These are the factors that are expected to drives the growth of this segment in the Parenteral Nutrition market during the forecast period 2024-2030.
Based on the End-Use, the parenteral nutrition market is segmented into Children and New-born, and Adults. Adults segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. Parenteral nutrition is a sustainable alternative for adult and paediatric patients with a functional gastrointestinal tract or illnesses that necessitate total bowel rest, such as certain phases of ulcerative colitis, intestinal obstruction, and post-surgical short bowel syndrome. Malnutrition is a common occurrence among severely unwell persons. Acute and chronic sickness, trauma and inflammation-induced stress-related catabolism, and drug-induced adverse effects, particularly in youngsters, may impair appetite or exacerbate nausea and vomiting. A rigorous nutritional assessment advised by healthcare specialists should be used to determine the prescribed doses of various nutrients for adults receiving parenteral feeding. Nutritional requirements should include disease-specific demands based on patient type, such as adults, children, and new-born babies, with considerations such as medical condition, nutritional status, fluid limits, and organ function all being taken into account.
Parenteral Nutrition Market Regional Insights:
North America region is expected to dominate the Parenteral Nutrition market during the forecast period 2024-2030. North America region is expected to hold the largest market shares of xx% by 2030. This is due to high research expenditures by the government of countries in the region, as well as private organizations operating in the healthcare sector, and collaborations between regulatory authorities, the medical device sector, and universities. These are the key major drivers that are expected to drives the growth of the North America region in the Parenteral Nutrition Market during the forecast period.
Asia Pacific region is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. This is due to the favorable government initiatives related to healthcare infrastructure development and reimbursement policies in countries in the region. Economic development in countries such as China, India, and Japan, and increasing government initiatives for development of healthcare infrastructure and implementation of reimbursement policies are factors supporting parenteral nutrition market growth in Asia Pacific region.
The objective of the report is to present a comprehensive analysis of the Parenteral Nutrition Market to the stakeholders in the industry. The report provides trends that are most dominant in the Parenteral Nutrition Market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.
The qualitative and quantitative data provided in the Parenteral Nutrition Market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Parenteral Nutrition Market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the market.
The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Market. The report also analyses if the Parenteral Nutrition Market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.
The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Parenteral Nutrition Market is aided by legal factors.
Parenteral Nutrition Market Scope:
|
Parenteral Nutrition Market |
|
|
Market Size in 2023 |
USD 7.18 Bn. |
|
Market Size in 2030 |
USD 10.80 Bn. |
|
CAGR (2024-2030) |
6% |
|
Historic Data |
2018-2022 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2030 |
|
Segment Scope |
By Nutrition Type
|
|
By Consumer Type
|
|
|
By End-Use
|
|
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Parenteral Nutrition Market Key Players
- Baxter
- Grifols, S.A.
- Allergan
- Otsuka Pharmaceutical Factory, Inc.
- Actavis Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Vifor Pharma
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Pfizer Inc. (Hospira Inc.)
- Titus Health Tech
- Health Biologics
- Radius Healthcare Private Limited
- A M Nutratech Private Limited
- Inlife Pharma Private Limited
Frequently Asked Questions
North America is expected to hold the highest share in the Parenteral Nutrition Market
Baxter, Grifols, S.A., Allergan, Otsuka Pharmaceutical Factory, Inc., Actavis Inc., and B. Braun Melsungen AG are the top key players in the Parenteral Nutrition Market
Single Dose Amino Acid Solution segment hold the largest market share in the Parenteral Nutrition market by 2030
The market size of the Parenteral Nutrition market is expected to reach US $ 10.80 Bn. by 2030.
The market size of the Parenteral Nutrition market was worth US $7.18 Bn. in 2023.
Chapter 1 Scope of the Report
Chapter 2 Research Methodology
2.1. Research Process
2.2. Global Parenteral Nutrition Market: Target Audience
2.3. Global Parenteral Nutrition Market: Primary Research (As per Client Requirement)
2.4. Global Parenteral Nutrition Market: Secondary Research
Chapter 3 Executive Summary
Chapter 4 Competitive Landscape
4.1. Market Share Analysis, By Value, 2023-2030
4.1.1. Market Share Analysis, By Region, By Value, 2023-2030 (In %)
4.1.1.1. North America Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.2. Europe Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.3. Asia Pacific Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.4. South America Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.5. Middle East and Africa Market Share Analysis, By Value, 2023-2030 (In %)
4.1.2. Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.1. North America Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.1.1. USA Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.1.2. Canada Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.1.3. Mexico Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2. Europe Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.1. UK Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.2. France Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.3. Germany Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.4. Italy Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.5. Spain Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.6. Sweden Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.7. Austria Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.2.8. Rest of Europe Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3. Asia Pacific Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3.1. China Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3.2. India Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3.3. Japan Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3.4. South Korea Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3.5. Australia Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3.6. ASEAN Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.3.7. Rest of APAC Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.4. South America Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.4.1. Brazil Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.4.2. Argentina Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.4.3. Rest of South America Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.5. Middle East and Africa Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.5.1. South Africa Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.5.2. GCC Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.5.3. Egypt Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.5.4. Nigeria Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.2.5.5. Rest of Middle East and Africa Market Share Analysis, By Nutrition Type, By Value, 2023-2030 (In %)
4.1.3. Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.1. North America Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.1.1. USA Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.1.2. Canada Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.1.3. Mexico Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2. Europe Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.1. UK Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.2. France Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.3. Germany Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.4. Italy Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.5. Spain Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.6. Sweden Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.7. Austria Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.2.8. Rest of Europe Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3. Asia Pacific Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3.1. China Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3.2. India Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3.3. Japan Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3.4. South Korea Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3.5. Australia Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3.6. ASEAN Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.3.7. Rest of APAC Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.4. South America Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.4.1. Brazil Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.4.2. Argentina Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.4.3. Rest of South America Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.5. Middle East and Africa Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.5.1. South Africa Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.5.2. GCC Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.5.3. Egypt Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.5.4. Nigeria Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.3.5.5. Rest of Middle East and Africa Market Share Analysis, By Consumer Type, By Value, 2023-2030 (In %)
4.1.4. Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.1. North America Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.1.1. USA Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.1.2. Canada Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.1.3. Mexico Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2. Europe Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.1. UK Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.2. France Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.3. Germany Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.4. Italy Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.5. Spain Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.6. Sweden Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.7. Austria Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.2.8. Rest of Europe Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3. Asia Pacific Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3.1. China Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3.2. India Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3.3. Japan Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3.4. South Korea Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3.5. Australia Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3.6. ASEAN Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.3.7. Rest of APAC Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.4. South America Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.4.1. Brazil Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.4.2. Argentina Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.4.3. Rest of South America Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.5. Middle East and Africa Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.5.1. South Africa Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.5.2. GCC Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.5.3. Egypt Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.5.4. Nigeria Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.1.4.5.5. Rest of Middle East and Africa Market Share Analysis, By End-Use, By Value, 2023-2030 (In %)
4.2. Stellar Competition matrix
4.2.1. Global Stellar Competition Matrix
4.2.2. North America Stellar Competition Matrix
4.2.3. Europe Stellar Competition Matrix
4.2.4. Asia Pacific Stellar Competition Matrix
4.2.5. South America Stellar Competition Matrix
4.2.6. Middle East and Africa Stellar Competition Matrix
4.3. Key Players Benchmarking
4.3.1. Key Players Benchmarking By Product, Pricing, Market Share, Investments, Expansion Plans, Physical Presence and Presence in the Market.
4.4. Mergers and Acquisitions in Industry
4.4.1. M&A by Region, Value and Strategic Intent
4.5. Market Dynamics
4.5.1. Market Drivers
4.5.2. Market Restraints
4.5.3. Market Opportunities
4.5.4. Market Challenges
4.5.5. PESTLE Analysis
4.5.6. PORTERS Five Force Analysis
4.5.7. Value Chain Analysis
Chapter 5 Global Parenteral Nutrition Market Segmentation: By Nutrition Type
5.1. Global Parenteral Nutrition Market, By Nutrition Type, Overview/Analysis, 2023-2030
5.2. Global Parenteral Nutrition Market, By Nutrition Type, By Value, Market Share (%), 2023-2030 (USD Million)
5.3. Global Parenteral Nutrition Market, By Nutrition Type, By Value, -
5.3.1. Carbohydrates
5.3.2. Lipid Emulsion
5.3.3. Single Dose Amino Acid Solution
5.3.4. Trace Elements
5.3.5. Vitamins and Minerals
Chapter 6 Global Parenteral Nutrition Market Segmentation: By Consumer Type
6.1. Global Parenteral Nutrition Market, By Consumer Type, Overview/Analysis, 2023-2030
6.2. Global Parenteral Nutrition Market Size, By Consumer Type, By Value, Market Share (%), 2023-2030 (USD Million)
6.3. Global Parenteral Nutrition Market, By Consumer Type, By Value, -
6.3.1. Children and New-born
6.3.2. Adults
Chapter 7 Global Parenteral Nutrition Market Segmentation: By End-Use
7.1. Global Parenteral Nutrition Market, By End-Use, Overview/Analysis, 2023-2030
7.2. Global Parenteral Nutrition Market Size, By End-Use, By Value, Market Share (%), 2023-2030 (USD Million)
7.3. Global Parenteral Nutrition Market, By End-Use, By Value, -
7.3.1. Hospital
7.3.2. Clinic
7.3.3. Others
Chapter 8 Global Parenteral Nutrition Market Segmentation: By Region
8.1. Global Parenteral Nutrition Market, By Region – North America
8.1.1. North America Parenteral Nutrition Market Size, By Nutrition Type, By Value, 2023-2030 (USD Million)
8.1.2. North America Parenteral Nutrition Market Size, By Consumer Type, By Value, 2023-2030 (USD Million)
8.1.3. North America Parenteral Nutrition Market Size, By End-Use, By Value, 2023-2030 (USD Million)
8.1.4. By Country – U.S.
8.1.4.1. U.S. Parenteral Nutrition Market Size, By Nutrition Type, By Value, 2023-2030 (USD Million)
8.1.4.2. U.S. Parenteral Nutrition Market Size, By Consumer Type, By Value, 2023-2030 (USD Million)
8.1.4.3. U.S. Parenteral Nutrition Market Size, By End-Use, By Value, 2023-2030 (USD Million)
8.1.4.4. Canada Parenteral Nutrition Market Size, By Value, 2023-2030 (USD Million)
8.1.4.5. Mexico Parenteral Nutrition Market Size, By Value, 2023-2030 (USD Million)
8.2. Europe Parenteral Nutrition Market Size, By Value, 2023-2030 (USD Million)
8.2.1. UK
8.2.2. France
8.2.3. Germany
8.2.4. Italy
8.2.5. Spain
8.2.6. Sweden
8.2.7. Austria
8.2.8. Rest of Europe
8.3. Asia Pacific Parenteral Nutrition Market Size, By Value, 2023-2030 (USD Million)
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. ASEAN
8.3.7. Rest of APAC
8.4. Middle East and Africa Parenteral Nutrition Market Size, By Value, 2023-2030 (USD Million)
8.4.1. South Africa
8.4.2. GCC
8.4.3. Egypt
8.4.4. Nigeria
8.4.5. Rest of Middle East and Africa
8.5. South America Parenteral Nutrition Market Size, By Value, 2023-2030 (USD Million)
8.5.1. Brazil
8.5.2. Argentina
8.5.3. Rest of South America
Chapter 9 Company Profiles
9.1. Key Players
9.1.1. Baxter
9.1.1.1. Company Overview
9.1.1.2. Tube Portfolio
9.1.1.3. Financial Overview
9.1.1.4. Business Strategy
9.1.1.5. Key Developments
9.1.2. Grifols, S.A.
9.1.3. Allergan
9.1.4. Otsuka Pharmaceutical Factory, Inc.
9.1.5. Actavis Inc.
9.1.6. B. Braun Melsungen AG
9.1.7. Fresenius Kabi AG
9.1.8. Vifor Pharma
9.1.9. Sichuan Kelun Pharmaceutical Co., Ltd.
9.1.10. Pfizer Inc. (Hospira Inc.)
9.1.11. Titus Health Tech
9.1.12. Health Biologics
9.1.13. Radius Healthcare Private Limited
9.1.14. A M Nutratech Private Limited
9.1.15. Inlife Pharma Private Limited
9.2. Key Findings
9.3. Recommendations
